Did you know that, while well established in the metastatic setting, second-generation antibody-drug conjugates are now moving into the early setting?

Credit available for this activity expires: 12/10/26
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/how-are-adcs-shaping-future-early-breast-cancer-care-latest-2025a1000yca?ecd=bdc_podcast_libsyn_mscpedu

Join the program for an in-depth discussion on low-grade glioma – from burden and diagnosis to therapies.

Credit available for this activity expires: 12/10/26
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/pediatric-low-grade-glioma-braf-alterations-stories-science-2025a1000x3w?ecd=bdc_podcast_libsyn_mscpedu

Join this program for relevant updates across the advanced and metastatic breast cancer (mBC) spectrum as presented in October 2025.

Credit available for this activity expires: 12/8/26
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/hot-topics-berlin-2025-what-experts-say-about-future-2025a1000x8r?ecd=bdc_podcast_libsyn_mscpedu

Where do oral selective estrogen receptor degraders (SERDs) fit in the overall landscape of first- and second-line advanced/metastatic breast cancer?

Credit available for this activity expires: 12/04/26
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/how-are-oral-serds-changing-management-advanced-hr-positive-2025a1000xkg?ecd=bdc_podcast_libsyn_mscpedu

Preventing the first ASCVD is critically important. In this activity, we explore the evidence for early and intensive lipid lowering to significantly reduce patient's cardiovascular (CV) risk.

Credit available for this activity expires: 12/05/26
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/staying-ahead-first-event-evaluating-evidence-early-ldl-c-2025a1000xkj?ecd=bdc_podcast_libsyn_mscpedu

Is your patient's proteinuria low enough? New KDIGO goals: target the immune cause and hit < 0.5 g/day to preserve kidney function.

Credit available for this activity expires: 12/2/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1003055?ecd=bdc_podcast_libsyn_mscpedu

Are you up to date on emerging pharmacologic therapies transforming obesity and type 2 diabetes care?

Credit available for this activity expires: 11/28/26
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/advances-pharmacologic-management-obesity-expert-digest-2025a1000v94